Skip to main content
Clinical Trials/JPRN-UMIN000017968
JPRN-UMIN000017968
Completed
未知

Retinal sensitivity in branch retinal vein occlusion after anti-VEGF therapy - Retinal sensitivity in BRVO after anti-VEGF therapy

Department of Ophthalmology, Fukushima Medical University0 sites50 target enrollmentStarted: June 19, 2015Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
Department of Ophthalmology, Fukushima Medical University
Enrollment
50

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional,observational

Eligibility Criteria

Ages
18years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with history of treatment for branch retinal vein occlusion, possibility of pregnancy, allergy for ranibizumab, intraocular infection or severe inflammation will be excluded.

Investigators

Sponsor
Department of Ophthalmology, Fukushima Medical University

Similar Trials